PAHC (Phibro Animal Health) Median PS Value: $40.54 (As of Aug. 08, 2026) — 6335% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PAHC Phibro Animal Health Corp PAHC
75 GF Score
Price $34.26
GF Value $29.54
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Phibro Animal Health Median PS Value?

Phibro Animal Health PAHC -3.41% 75 Median PS Value is $40.54 as of Aug. 08, 2026, which is 6335% above its 10-year median of 0.63. GuruFocus rates PAHC with a GF Score™ of 75/100 and a GF Value™ of $29.54 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 546 Drug Manufacturers companies, Phibro Animal Health ranks better than 50.37% on this metric.

This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Phibro Animal Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $36.681. Phibro Animal Health's 10-Year median PS Ratio is 1.1052. Therefore, the Median PS Value for today is $40.54.

As of today (2026-08-08), Phibro Animal Health's share price is $34.26. Phibro Animal Health's Median PS Value is $40.54. Therefore, Phibro Animal Health's Price to Median PS Value for today is 0.85.

The historical rank and industry rank for Phibro Animal Health's Median PS Value or its related term are showing as below:

PAHC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.38   Med: 0.63   Max: 1.36
Current: 0.85

During the past 13 years, the highest Price to Median PS Value of Phibro Animal Health was 1.36. The lowest was 0.38. And the median was 0.63.

PAHC's Price-to-Median-PS-Value is ranked better than
50.37% of 546 companies
in the Drug Manufacturers industry
Industry Median: 0.88 vs PAHC: 0.85

Phibro Animal Health  (NAS:PAHC) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Phibro Animal Health's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=34.26/40.54
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Phibro Animal Health Median PS Value Related Terms


Phibro Animal Health Median PS Value Historical Data

* Premium members only.

The historical data trend for Phibro Animal Health's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phibro Animal Health Median PS Value Chart

Phibro Animal Health Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 31.47 35.25

Phibro Animal Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.03 35.25 37.96 39.60 40.54

PAHC vs PRGO, HROW, XERS: Median PS Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Phibro Animal Health's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Phibro Animal Health Price-to-Median-PS-Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phibro Animal Health's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Phibro Animal Health's Price-to-Median-PS-Value falls into.


PAHC
75GF Score
Phibro Animal Health Corp PAHC
Median PS Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Phibro Animal Health Median PS Value Calculation

Phibro Animal Health's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=36.681*1.1052
=40.54

10-Year Median PS Ratio is 1.1052.
Phibro Animal Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $36.681.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Median PS Value →
What does a Median PS Value of $40.54 mean?
Phibro Animal Health (PAHC) has a Median PS Value of $40.54 as of Aug. 08, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Phibro Animal Health and its competitors. This is 6335% above median its historical median of 0.63. Over the past decade, Phibro Animal Health's Median PS Value has ranged from 0.38 to 1.36. According to the industry distribution chart, Phibro Animal Health ranks #271 out of 546 companies in the Drug Manufacturers industry, placing it in the top 49.6%.
Is Phibro Animal Health's Median PS Value too high?
Phibro Animal Health's current Median PS Value of $40.54 is 6335% above median its 10-year median of 0.63. Over the past 10 years, this metric has ranged from a low of 0.38 to a high of 1.36. The Drug Manufacturers industry median Median PS Value is 0.88. Phibro Animal Health's value of $40.54 is 4506.8% above this industry median. Based on the distribution chart, Phibro Animal Health ranks #271 out of 546 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Phibro Animal Health has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Phibro Animal Health's Median PS Value compare to PRGO and HROW?
According to the Drug Manufacturers industry distribution chart, Phibro Animal Health ranks #271 out of 546 companies for Median PS Value. This puts Phibro Animal Health in the upper half of its industry. The industry median Median PS Value is 0.88. Phibro Animal Health's value of $40.54 is 4506.8% above this benchmark. Historically, Phibro Animal Health's own Median PS Value has ranged from 0.38 to 1.36 over the past decade. While the company's 10-year median is 0.63 vs. the industry median of 0.88, Phibro Animal Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.88, based on 546 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Phibro Animal Health's current Median PS Value of $40.54 is 4506.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Phibro Animal Health and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Phibro Animal Health's current Median PS Value is $40.54, which is 6335% above median its own 10-year median of 0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Phibro Animal Health stock overvalued right now?
Based on GuruFocus' analysis, Phibro Animal Health (PAHC) is currently considered Modestly Overvalued. The stock's GF Value™ is $29.54, compared to a current price of $34.26 — trading 16% above its estimated fair value. The current Median PS Value is $40.54, which is 6335% above median its 10-year median of 0.63 and 4506.8% above the Drug Manufacturers industry median of 0.88. Phibro Animal Health's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Phibro Animal Health (PAHC), the current Median PS Value is $40.54 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Phibro Animal Health (PAHC) Overvalued in 2026?

Based on GuruFocus' analysis, Phibro Animal Health stock appears to be overvalued. The current stock price of $34.26 is trading 16% above its estimated GF Value™ of $29.54. GuruFocus considers Phibro Animal Health to be Modestly Overvalued.

Key valuation signals for PAHC:

  • Median PS Value: $40.54 (6335% above median its 10-year median of 0.63)
  • GF Value™: $29.54 vs. price of $34.26 (16% above fair value)
  • GF Score™: 75/100 with 4 warning signs
  • Industry Position: 4506.8% above the Drug Manufacturers median (#271 of 546)

No single metric tells the full story. See the PAHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Phibro Animal Health Business Description

Other Exchanges PB8:Germany
Address 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
75GF Score

Get the complete analysis for PAHC

Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.26
Price
$29.54
GF Value